This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Topadur Pharma Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Selena Di Maio
Introduction
Selena Di Maio is a prominent inventor based in Schlieren, Switzerland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for therapeutic applications. Her work focuses on enhancing the efficacy of treatments through innovative chemical formulations.
Latest Patents
Selena Di Maio holds a patent for a groundbreaking invention titled "Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof." This patent describes compounds that include specific chemical moieties designed to treat or prevent diseases alleviated by the inhibition of PDE5 in humans and non-human mammals. The patent outlines various formulations and their potential applications in medical treatments.
Career Highlights
Throughout her career, Selena has demonstrated a strong commitment to advancing medical science. She is currently associated with Topadur Pharma AG, where she continues to innovate and develop new therapeutic solutions. Her work has garnered attention for its potential impact on patient care and treatment outcomes.
Collaborations
Selena has collaborated with notable professionals in her field, including Guido Koch and Esra Lone. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and scope of her research.
Conclusion
Selena Di Maio's contributions to the field of pharmaceuticals exemplify the importance of innovation in developing effective treatments. Her patent and ongoing work at Topadur Pharma AG highlight her role as a key figure in advancing medical science.